Ocugen Inc.

12/09/2021 | Press release | Distributed by Public on 12/09/2021 06:31

Ocugen, Inc. Announces U.S. FDA Acceptance of Investigational New Drug Application to Initiate a Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited[...]